(Q34594521)

3 August 2017

1 reference

title

Anticonvulsants to treat idiopathic restless legs syndrome: systematic review (English)

1 reference

3 August 2017

main subject

restless legs syndrome

0 references

1 reference

Cristiane Fiquene Conti

1

1 reference

3 August 2017

Márcio Moysés de Oliveira

2

1 reference

3 August 2017

Juliana Spelta Valbuza

3

1 reference

3 August 2017

Lucila Bizari F Prado

4

1 reference

3 August 2017

Luciane Bizari Coin de Carvalho

5

1 reference

3 August 2017

Gilmar Fernandes do Prado

6

1 reference

3 August 2017

publication date

1 June 2008

1 reference

Arquivos de Neuro-Psiquiatria

3 August 2017

published in

1 reference

3 August 2017

volume

66

1 reference

3 August 2017

issue

2B

1 reference

3 August 2017

page(s)

431-435

1 reference

The restless legs syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: frequency, biochemical findings and comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Restless legs syndrome: clinicoetiologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Reduction of 3,4-diaminopyridine-induced biogenic amine synthesis and release in rat brain by gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Treatment of idiopathic restless legs syndrome (RLS) with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

Pilot trial of lamotrigine in the restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-282X2008000300034

10.1590/S0004-282X2008000300034

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference